Radiological changes in rheumatoid arthritis patients at a teaching hospital in saudi Arabia;Modifications radiologiques chez des patients atteints de polyarthrite rhumatoïde dans un hôpital universitaire en arabie saoudite

Eastern Mediterranean Health Journal

Volumn 16, Issue 9, 2010, Pages 953-957

  Attar, S M ^a   Al Ghamdi, A ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

ADULT; ARTICLE; BONE EROSION; DEFORMITY; DISEASE DURATION; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OUTPATIENT DEPARTMENT; RHEUMATOID ARTHRITIS; SAUDI ARABIA; SOFT TISSUE DISEASE; SWELLING; TEACHING HOSPITAL;

EID: 78751635460     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.9.953     Document Type: Article

References (37)

1. Mimori T. Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Internal Medicine (Tokyo, Japan), 2005, 44:1122-1126.
2. Boire G et al. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Arthritis Research and Therapy, 2005, 7:592-603.
3. Gerard A et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis and Rheumatism, 2000, 43:155-163.
4. Sokka T. Work disability in early rheumatoid arthritis. Clinical and Experimental Rheumatology, 2003, 21(5 Suppl. 31):S71-S74.
5. Valiukiene K, Butrimiene I, Venalis A. The dynamic of radiological changes in early rheumatoid arthritis patients treated with methotrexate and sulphasalazine. Acta Medica Lituanica, 2001, 8(1):52-56.
6. Nurmohamed MT, Dijkmans BA. Are biologics more effective than classical disease-modifying antirheumatic drugs? Arthritis Research and Therapy, 2008, 10(5):118.
7. Nurmohamed MT, Dijkmans BA. Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis. Drugs, 2005, 65(5):661-694.
8. Lorenz HM. Biological agents: a novel approach to the therapy of rheumatoid arthritis. Expert Opinion on Investigational Drugs, 2000, 9(7):1479-1490.
9. Arnett FC et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism, 1988, 31(3):315-324.
10. Visser H. Early diagnosis of rheumatoid arthritis. Best Practice and Research. Clinical Rheumatology, 2004, 19(1):55-72.
11. Van der Heijde DM et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow up of patients with early rheumatoid arthritis. Arthritis and Rheumatism, 1992, 35(1):26-34.
12. Fuchs HA et al. Evidence of significant radiographic damage in rheumatoid arthritis with in the first 2 years of disease. Journal of Rheumatology, 1989, 16(5):585-591.
13. Van der Heijde DM et al. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification Journal of Rheumatology, 1995, 22(9):1792-1796.
14. Hulsmans HM et al. The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis and Rheumatism, 2000, 43(9):1927-1940.
15. Listing J et al. HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group. Journal of Rheumatology, 2000, 27(9):2100-2109.
16. Lindqvist E et al. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Annals of the Rheumatic Diseases, 2003, 62(7):611-616.
17. Flatø B et al. The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis. Arthritis and Rheumatism, 2002, 46(4):986-994.
18. Vencovský J et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Annals of the Rheumatic Diseases, 2003, 62(5):427-430.
19. Massardo L et al. The presence of the HLA-DRB1 shared epitope correlates with erosive disease in Chilean patients with rheumatoid arthritis. Rheumatology (Oxford), 2002, 41(2):153-156.
20. Combe B et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis and Rheumatism, 2001, 44(8):1736-1743.
21. Lindqvist E et al. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Annals of the Rheumatic Diseases, 2005, 64(2):196-201.
22. Al-Dalaan A et al. The prevalence of rheumatoid arthritis in the Qassim region of Saudi Arabia. Annals of Saudi Medicine, 1998, 18(5):396-397.
23. Al-Boukai AA, Al-Arfaj AS. Patterns of radiographic changes in hands and feet of rheumatoid arthritis in Saudi Arabia. Saudi Medical Journal, 2003, 24(4):396-399.
24. Prevoo ML et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism, 1995, 38(1):44-48.
25. Möttönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Annals of the Rheumatic Diseases, 1988, 47(8):648-653.
26. Al-Salem IH, Al-Awadhi AM. The expression of rheumatoid arthritis in Kuwaiti patients in an outpatient hospital-based practice. Medical Principles and Practice, 2004, 13(1):47-50.
27. Al-Attia HM et al. Rheumatoid arthritis in a population sample in the Gulf: clinical observations. Clinical Rheumatology, 1993, 12(4):506-510.
28. Badsha H, Kong KO, Tak PP. Rheumatoid arthritis in the United Arab Emirates. Clinical Rheumatology, 2008, 27(6):739-742.
29. Al-Rawi ZS et al. Rheumatoid arthritis in population samples in Iraq. Annals of the Rheumatic Diseases, 1978, 37(1):73-75.
30. Zayed A et al. Some biochemical changes in serum and synovial fluid in patients with rheumatoid arthritis. Journal of Medical Science, 2007, 7(4):526-535.
31. Jarallah JS et al. Prevalence and determinants of smoking in three regions of Saudi Arabia. Tobacco control, 1999, 8:53-56.
32. Al-Arfaj AS. Characteristics of rheumatoid arthritis relative to HLA-DR in Saudi Arabia. Saudi Medical Journal, 2001, 22(7):595-598.
33. Coruh B et al. Does religious activity improve health outcomes? A critical review of the recent literature. Explore (NY), 2005, 1(3):186-191.
34. Yoshino S, Shoji H, Komagamine M. Full flexion after total knee replacement in rheumatoid arthritis. International Orthopaedics, 1990, 14(1):13-16.
35. Szabó G et al. A prospective comparative analysis of mobility in osteoarthritic knees. Journal of Bone and Joint Surgery. British Volume, 2000, 82(8):1167-1169.
36. Rønningen A, Kjeken I. Effect of an intensive hand exercise programme in patients with rheumatoid arthritis. Scandinavian Journal of Occupational Therapy, 2008, 7:1-11.
37. De Jong Z et al. Long term high intensity exercise and damage of small joints in rheumatoid arthritis. Annals of the Rheumatic Diseases, 2004, 63(11):1399-1405.